Biolase Wins FDA Clearance for Laser Root Canal

SAN CLEMENTE, Calif., Jan. 29 -- Biolase Technology Inc. has received FDA clearance for complete hard- and soft-tissue laser root-canal therapy. The company can now market its Waterlase technology for root-canal procedures for both hard- and soft-tissue procedures, which will broaden the applications that dentists and specialists, such as endodontists, can perform with the YSGG laser.

This clearance covers all enamel, dentin, pulpal and diseased-tissue removal, shaping and cleaning aspects of root canal therapy. This includes tooth preparation to obtain access to the root canal, pulpotomy, pulp extirpation, pulpotomy as an adjunct to root canal, root-canal debridement and cleaning and root-canal preparation, including enlargement.